Cytovale’s Diagnostic Test Demonstrates Strong Performance in Rapid Identification of Sepsis Risk, Peer-Review Study Confirms

Large scale study confirms Cytovale’s IntelliSep test accurately predicts sepsis risk and severity, aids in appropriate triage and treatment pathways in emergency departments SAN FRANCISCO, May 2, 2024 /PRNewswire/ — Cytovale®, a commercial-stage medical diagnostics company focused on…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks